3 documents

Read All
21:18 , Jan 9, 2019 |  BC Extra  |  Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

Paul-Peter Tak has stepped down from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to join Flagship Pioneering as a venture partner. He was GSK's SVP of R&D, chief immunology officer and development lead. Evercore ISI hired Ravi Mehrotra...
Read More
07:00 , Sep 26, 2016 |  BC Week In Review  |  Financial News

Cellenkos completes venture financing

Cellenkos Inc. , Houston, Texas   Business: Gene/Cell therapy, Autoimmune   Date completed: 2016-09-18   Type: Venture financing   Raised: $10 million   Investors: Golden Meditech Holdings Ltd.; and an undisclosed investor  ...
Read More
07:00 , Sep 20, 2016 |  BC Extra  |  Financial News

Cellenkos raises $10M venture round

The University of Texas MD Anderson Cancer Center and Golden Meditech Ltd. (HKSE:00801; Taiwan:910801) launched immunotherapy newco Cellenkos Inc. (Houston, Texas) with $10 million in a venture round. Golden Meditech and an undisclosed strategic investor...
Read More